Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/051281external-prioritypatent/WO2009098236A1/en
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of TN2010000363A1publicationCriticalpatent/TN2010000363A1/en
208000037265diseases, disorders, signs and symptomsDiseases0.000abstract1
239000003814drugSubstances0.000abstract1
230000001404mediated effectEffects0.000abstract1
150000003839saltsChemical class0.000abstract1
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
The invention relates to compounds of formula (I) and salts thereof formula (I), wherein the substituens are as defined in the specification, processes for the preparation thereof; to pharmaceuticals containing such compounds, in particular for the use in one or more Protein tyrosine kinase mediated diseases.
TNP2010000363A2009-02-042010-08-02Pyrrolo [2,3-d] pyridines and use thereof as tyrosine kinase inhibitors
TN2010000363A1
(en)